These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 33454213)

  • 1. The Counter Regulatory Axis of the Lung Renin-Angiotensin System in Severe COVID-19: Pathophysiology and Clinical Implications.
    Triposkiadis F; Starling RC; Xanthopoulos A; Butler J; Boudoulas H
    Heart Lung Circ; 2021 Jun; 30(6):786-794. PubMed ID: 33454213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury.
    Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F
    Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System.
    Edmonston DL; South AM; Sparks MA; Cohen JB
    Adv Chronic Kidney Dis; 2020 Sep; 27(5):404-411. PubMed ID: 33308506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
    Cheng H; Wang Y; Wang GQ
    J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin system at the interface of COVID-19 infection.
    Gul R; Kim UH; Alfadda AA
    Eur J Pharmacol; 2021 Jan; 890():173656. PubMed ID: 33086029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.
    Malek Mahdavi A
    Rev Med Virol; 2020 Sep; 30(5):e2119. PubMed ID: 32584474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manipulation of ACE2 expression in COVID-19.
    Chaudhry F; Lavandero S; Xie X; Sabharwal B; Zheng YY; Correa A; Narula J; Levy P
    Open Heart; 2020 Dec; 7(2):. PubMed ID: 33443121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure.
    Angeli F; Zappa M; Reboldi G; Gentile G; Trapasso M; Spanevello A; Verdecchia P
    Eur J Intern Med; 2023 Mar; 109():12-21. PubMed ID: 36528504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II receptors: Impact for COVID-19 severity.
    Aksoy H; Karadag AS; Wollina U
    Dermatol Ther; 2020 Nov; 33(6):e13989. PubMed ID: 32645228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.
    Gheblawi M; Wang K; Viveiros A; Nguyen Q; Zhong JC; Turner AJ; Raizada MK; Grant MB; Oudit GY
    Circ Res; 2020 May; 126(10):1456-1474. PubMed ID: 32264791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease.
    Kuriakose J; Montezano AC; Touyz RM
    Clin Sci (Lond); 2021 Jan; 135(2):387-407. PubMed ID: 33511992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of renin-angiotensin system and COVID-19: the importance of daily rhythms in ACE2, ADAM17 and TMPRSS2 expression.
    Zlacká J; Stebelová K; Zeman M; Herichová I
    Physiol Res; 2021 Dec; 70(S2):S177-S194. PubMed ID: 34913351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury.
    Oz M; Lorke DE
    Biomed Pharmacother; 2021 Apr; 136():111193. PubMed ID: 33461019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repressed Ang 1-7 in COVID-19 Is Inversely Associated with Inflammation and Coagulation.
    Carpenter RM; Young MK; Petri WAO; Lyons GR; Gilchrist C; Carey RM; Petri WA
    mSphere; 2022 Aug; 7(4):e0022022. PubMed ID: 35913134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment.
    Chappell MC
    Circ Res; 2023 May; 132(10):1320-1337. PubMed ID: 37167353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE2, the Counter-Regulatory Renin-Angiotensin System Axis and COVID-19 Severity.
    Triposkiadis F; Xanthopoulos A; Giamouzis G; Boudoulas KD; Starling RC; Skoularigis J; Boudoulas H; Iliodromitis E
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE2 and COVID-19 and the resulting ARDS.
    Zhang X; Li S; Niu S
    Postgrad Med J; 2020 Jul; 96(1137):403-407. PubMed ID: 32522846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019.
    Suh SH; Ma SK; Kim SW; Bae EH
    Korean J Intern Med; 2021 Mar; 36(2):247-262. PubMed ID: 33617712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases.
    Sharma RK; Li J; Krishnan S; Richards EM; Raizada MK; Mohandas R
    Clin Sci (Lond); 2021 Jan; 135(1):1-17. PubMed ID: 33399851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.